Gilead Sciences (GILD) Stock News
$GILD · NASDAQ · HEALTHCARE · 3 stories in 30 days$155.89
1D −0.94%1W +6.98%1M +6.56%
BORSA has published 3 stories on Gilead Sciences (GILD) in the past 30 days. BORSA’s news read on GILD is leaning bullish at 56/100, unchanged over 24 hours, based on 3 company events over the past 30 days. GILD last closed at $157.37 on Oct 15, up 6.98% over five sessions and up 6.56% over the past month. Gilead Sciences’ next earnings report is scheduled for Thursday, Oct 29.
The wire on $GILD
newest first · updated · direct subject stories onlyRBC Capital lifts Gilead Sciences price target to $126.00
RBC Capital increased its price target for Gilead Sciences to $126.00 per share.
bullish 65 · impact 30Cantor Fitzgerald maintains $155.00 price target for Gilead Sciences
Cantor Fitzgerald maintained its price target for Gilead Sciences at $155.00 per share.
neutral 50 · impact 20